SCHEMBL3610280

SCHEMBL3610280

COc1ccc(OC)c(C([O])C=O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.59
CYP2D6 P10635 2/20 0.53
ADRA1A P35348 3/20 0.51
ADRA2A P08913 2/20 0.51
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
ACHE P22303 1/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPK1 P28482 1/20 0.49
BLM P54132 1/20 0.49
ALDH1A1 P00352 2/20 0.49
CA12 O43570 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
GAA P10253 1/20 0.47
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
ADRB3 P13945 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2928368 0.84 HTT (0.58) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL28963070 0.84 HTT (0.58) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL4981765 0.84 HTT (0.66) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL6543258 0.81 HTT (0.58) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL27546835 0.80 HTT (0.54) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL9027223 0.79 CYP2D6 (0.62) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL27624794 0.78 CYP2D6 (0.56) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL14856226 0.78 HTT (0.51) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL3070294 0.77 CYP2D6 (0.59) HTTCYP2D6ADRA1AADRA2ACA1
SCHEMBL487152 0.75 CYP2D6 (0.67) HTTCYP2D6ADRA1AADRA2ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100076005-A1 ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES UNIBIOSCREEN SA (BE) 2010-03-25 US disclosed
EP-2089395-A2 NEW ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES UnibioScreen S.A. (BE) 2009-08-19 EP disclosed
WO-2008043846-A2 NEW ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES UNIBIOSCREEN SA (BE) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076005-A1 ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES MIF, IMPDH1, IMPDH2 HTT 3982/4885CYP2D6 575/4885ADRA1A 2699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.